Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Prevenar co-administered with Infanrix Hexa in healthy children
2007-003692-39Phase 4Completed
- Sponsor
- IRCCS Ospedale Policlinico San Martino
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of pneumococcal 7-valent conjugate vaccine and pertussis filamentous haemagglutinin in pneumococcal disease, diphtheria, Tetanus and 4 more (2 arms), sponsored by IRCCS Ospedale Policlinico San Martino. Primary endpoints: Immunogenicity of Infanrix Hexa when administered alone or with Prevenar and Non-inferiority of co-administered Infanrix Hexa. Started Jul 2007; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccinepertussis filamentous haemagglutinin
03
Conditions
pneumococcal diseasediphtheriaTetanuspertussishepatitis B (HBV)
Beyond the preview
Go deeper on 2007-003692-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003692-39.